Posted on

HERE WE GO AGAIN: THE BEST HIGHFALUTIN ADVICE BIOTECH MONEY CAN BUY. PERPLEXING REVELATIONS OF PREJUDICE AND UNDISCLOSED FINANCIAL CONFLICTS OF INTEREST FROM FEDERAL ADVISORY PANEL.

A formal letter – signed by well-respected public interest leaders – asserts and substantiates overt systemic bias from the formerly respected National Academy Advisory Panel.
Millions of dollars of Biotech blood money and influence have perverted taxpayer-funds spent in the failed effort to achieve honest policy clarity on GMOs.
Dr. Jonathan Latham – one of the letter’s signatories – a scientist with deep integrity authors this valuable dispatch about the sordid state of affairs and Biotech’s serial stacking-the-deck and buying of influence. Jim

“The letter cites a lack of balance, perspective and independence among experts chosen to carry out a taxpayer-funded National Academy study. These experts will advise the federal government on how to overhaul regulations concerning GMOs — including novel biotechnology products developed using synthetic biology and other techniques, such as DNA ‘editing’….

“…However, at least six of the 13 committee members chosen have financial conflicts of interests with the biotech industry, four of which are not publicly disclosed. Several other committee members have backgrounds advocating biotechnology development…

“In contrast to the large presence of industry supporters in the Academy’s work, no strong advocates of the precautionary principle or critics of industry practices were invited to participate as committee members, even though many were nominated. Likewise, no farmers or farmer groups — nor consumers or consumer groups — were invited, even though the focus of the Academy’s work is on agricultural biotechnology and food products.”

http://www.truth-out.org/news/item/36676-financial-conflicts-at-national-academy-advisory-panel-on-the-future-of-gmo-regulation?tmpl=component&print=1